A mouse gene knockout model for juvenile ceroid‐lipofuscinosis (batten disease)

The human hereditary ceroid‐lipofuscinoses are a group of autosomal recessively inherited diseases characterized by massive accumulations of autofluorescent lysosomal storage bodies in the cells of many tissues and by neuronal degeneration throughout the central nervous system. There are a number of clinically and genetically distinct forms of ceroid‐lipofuscinosis, the most common of which is the juvenile type, also known as Batten disease and CLN3. To study the mechanisms that lead to pathology in CLN3 and to evaluate potential therapies, a mouse model has been generated by targeted disruption of the mouse ortholog of the CLN3 gene (Cln3). As in affected humans, mice homozygous for the disrupted Cln3 allele show accumulation of autofluorescent storage material in neurons and other cell types. The storage material consists of membrane‐bounded intracellular inclusions with ultrastructural features typical of the ceroid‐lipofuscinoses. The accumulation of this storage material validates the Cln3 knockout mice as a model for the human disorder. J. Neurosci. Res. 57:551–556, 1999. © 1999 Wiley‐Liss, Inc.

[1]  C. Zhou,et al.  Ovine neuronal ceroid lipofuscinosis: a large animal model syntenic with the human neuronal ceroid lipofuscinosis variant CLN6. , 1998, Journal of medical genetics.

[2]  G. Johnson,et al.  Coding sequence and exon/intron organization of the canine CLN3 (batten disease) gene and its exclusion as the locus for ceroid‐lipofuscinosis in english setter dogs , 1998, Journal of neuroscience research.

[3]  L. Peltonen,et al.  Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. , 1998, Human molecular genetics.

[4]  G. Johnson,et al.  Immunochemical localization of the Batten disease (CLN3) protein in retina. , 1997, Investigative ophthalmology & visual science.

[5]  M. Katz,et al.  Dietary carnitine supplements slow disease progression in a putative mouse model for hereditary ceroid‐lipofuscinosis , 1997, Journal of neuroscience research.

[6]  M. Katz,et al.  Formation of lipofuscin-like fluorophores by reaction of retinal with photoreceptor outer segments and liposomes , 1996, Mechanisms of Ageing and Development.

[7]  T. Lerner,et al.  Isolation and chromosomal mapping of a mouse homolog of the Batten disease gene CLN3. , 1996, Genomics.

[8]  J. Haines,et al.  Isolation of a novel gene underlying batten disease, CLN3 , 1995, Cell.

[9]  K. Wisniewski,et al.  Classification of the neuronal ceroid-lipofuscinoses: expansion of the atypical forms. , 1995, American journal of medical genetics.

[10]  R. Jolly Comparative biology of the neuronal ceroid-lipofuscinoses (NCL): an overview. , 1995, American journal of medical genetics.

[11]  M. Bennett,et al.  JUVENILE NEURONAL CEROID LIPOFUSCINOSIS: DEVELOPMENTAL PROGRESS AFTER SUPPLEMENTATION WITH POLYUNSATURATED FATTY ACIDS , 1994 .

[12]  G. Johnson,et al.  Two polymorphic microsatellites in a coding segment of the canine androgen receptor gene. , 2009, Animal genetics.

[13]  W. Frankel,et al.  Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of amyotrophic lateral sclerosis (ALS). , 1992, Genomics.

[14]  N. Koppang English setter model and juvenile ceroid-lipofuscinosis in man. , 1992, American journal of medical genetics.

[15]  J. Alroy,et al.  Clinical classification of neuronal ceroid-lipofuscinosis subtypes. , 1988, American journal of medical genetics. Supplement.

[16]  J. Opitz,et al.  Clinico-pathological variability in the childhood neuronal ceroid-lipofuscinoses and new observations on glycoprotein abnormalities. , 1988, American journal of medical genetics. Supplement.

[17]  M. Katz,et al.  Evidence of cell loss from the rat retina during senescence. , 1986, Experimental eye research.

[18]  T. Westermarck,et al.  Antioxidant therapy in neuronal ceroid-lipofuscinosis. , 1984, Medical biology.

[19]  C. Bucana,et al.  Blood levels of α-tocopherol in a disorder of lipid peroxidation: Batten's disease , 1974 .